3.8 C
Munich
Saturday, April 5, 2025
type here...
- Advertisement -spot_img

CATEGORY

Uncategorized

    Uncategorized

    Sangamo Gets Lifeline From Eli Lilly In $1.4 Billion Dollar Deal For Proprietary AAV Capsid

    pharmadigz_xixo9l -
    It was just announced that Sangamo Therapeutics entered into a licensing agreement with Eli Lilly to advance a proprietary STAC-BBB AAV capsid. This is...
    Uncategorized

    Second FDA Rejection Of Aldeyra Therapeutics But Hope Remains With Two Upcoming Events

    pharmadigz_xixo9l -
    It was announced today that Aldeyra Therapeutics had received a Complete Response Letter or CRL from the FDA of its drug reproxalap for the...
    Uncategorized

    Latest Corcept Data Could Lead To New Standard Of Care Option for Platinum-Resistant Ovarian Cancer Patients

    pharmadigz_xixo9l -
    Corcept Therapeutics is on a roll the last month, because it had been able to establish two key events from its pipeline. For starters,...
    Uncategorized

    Cassava Sciences Scraps Alzheimer’s Drug Development Of Simufilam After Latest Trial Failure

    pharmadigz_xixo9l -
    Cassava Sciences recently reported results from its second of two phase 3 studies known as REFOCUS-ALZ. This was a huge study as it recruited...
    Uncategorized

    Lexicon Establishes $1 Billion Milestone Deal With Novo Nordisk To Advance Weight Loss Drug LX9851

    pharmadigz_xixo9l -
    / Lexicon Pharmaceuticals was able to establish a deal with Novo Nordisk, whereby the big pharma obtained an exclusive, worldwide license for LX9851 for the...

    Latest news

    - Advertisement -spot_img

    © Munich, LLC. All rights reserved. Pulses Pro® is a registered U.S. trademark of tagDiv, LLC.

    About Us

    Popular Category

      Editor Picks